Well, it makes more sense to use data from a successful clinical trial that has actually received FDA approval, as opposed to the mess you lot at MSB have.
Ann: Further GvHD Clinical Data Published in Nature Medicine, page-5
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.005(2.13%) |
Mkt cap ! $43.36M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.0¢ | 24.0¢ | $527 | 2.195K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 8678 | 24.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 25.0¢ | 110370 | 3 |
View Market Depth
| Last trade - 13.01pm 15/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |